Trial intelligence / Profile preview

Ciprofol versus propofol for recovery quality after radical esophagectomy in older adults

ChiCTR2500103737Phase 4Not yet recruiting

Sponsor
Liaoning Province Cancer Hospital
Start
Jun 2025
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of ciprofol and propofol in esophageal cancer (2 arms), sponsored by Liaoning Province Cancer Hospital. Primary endpoint: Quality of recovery. Planned start Jun 2025; status: not yet recruiting.

02

Drugs

ciprofolpropofol
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on ChiCTR2500103737.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500103737.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call